C83.31
Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma that affects B lymphocytes, a kind of white blood cell crucial for immune defense. When this lymphoma occurs in the lymph nodes of the head, face, and neck, it can lead to noticeable swelling, discomfort, and other health concerns. DLBCL is characterized by rapid growth but can often be treated successfully if diagnosed early. Understanding the nature of this condition helps patients recognize symptoms and seek appropriate medical care.
Causes & Symptoms
Clinical Causes: Genetic mutations that cause B cells to grow uncontrollably. Exposure to certain chemicals or chemicals used in chemotherapy or radiation therapy. Weakened immune system due to infections such as HIV/AIDS or immunosuppressive medications. A history of other lymphomas or cancers. Age, as the condition is more common in older adults.
Key Symptoms: Noticeable swelling or lumps in the lymph nodes of the head, face, or neck. Persistent fatigue and weakness. Unexplained weight loss. Fever that doesn't go away. Night sweats. Pain or discomfort in the affected areas. Difficulty swallowing or breathing if lymph nodes press on nearby structures.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of physical examinations, imaging tests such as CT or PET scans, and laboratory procedures. A biopsy, where a small sample of tissue from an affected lymph node is examined under a microscope, confirms the presence of DLBCL. Additional blood tests and bone marrow biopsies may also be performed to assess the extent of the disease and guide treatment planning.
Treatment Protocols: Treatment options for diffuse large B-cell lymphoma typically include chemotherapy, often combined with targeted therapies. In some cases, radiation therapy or immunotherapy may be recommended. The specific regimen depends on factors such as the stage of the disease and the patient's overall health. Advances in treatment have improved survival rates, and clinical trials are ongoing to explore new therapeutic approaches. Supportive care to manage symptoms and side effects is also an important aspect of treatment.
Clinical Advice & FAQs
Billing Guidance
Is C83.31 a billable ICD-10 code?
Yes, C83.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.31?
Clinical documentation must specify the nature of Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference